Request Trial
shutterstock_1595586766_ken_wolter
Ken Wolter / Shutterstock.com
1 March 2022AmericasAlex Baldwin

USPTO rules Broad owns CRISPR animal cell editing patents

Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office (USPTO) has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Eli Lilly’s Mounjaro tops list of cyber squatter targets
28 January 2026   The rise of fake online stores selling counterfeit pharmaceuticals is driving a surge in domain name disputes, forcing major brands to defend revenue and reputation.
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026   As quantum-enabled innovation accelerates, patentability will hinge on predictability, disclosure, and modality-specific claim drafting in an increasingly unforgiving enablement landscape, explain Ray Miller and Joseph Wolfe of DLA Piper
Americas
Fed Circ overturns PTAB decision in $83.4m DNA case
26 January 2026   The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent.


Editor's picks

The quantum advantage: IP considerations for the next generation of life sciences innovation
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026

Editor's picks

Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026

More features

Eli Lilly’s Mounjaro tops list of cyber squatter targets
The quantum advantage: IP considerations for the next generation of life sciences innovation
Fed Circ overturns PTAB decision in $83.4m DNA case
Simpson Thacher adds ‘exemplary’ litigator with emerging tech expertise
AI is transforming top 100 innovators, shows index
Novartis win blocks generics relitigating $7.8bn heart drug patent
Leading the arena: WIPR identifies the top US trade secrets specialists of 2025
Rooted in rights: Lessons from plant patent infringement and invalidity cases